Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Cassava Sciences Inc (FLNA) vs VanEck Australian Floating Rate ETF (FLOT) Price & Performance

Cassava Sciences IncTrade
VanEck Australian Floating Rate ETFTrade

Price performance (Past 24H)

Key statistics

Cassava Sciences Inc vs VanEck Australian Floating Rate ETF — how do they compare? Cassava Sciences Inc trades at $1.06 (market cap $53.14M), while VanEck Australian Floating Rate ETF trades at $50.97. The key difference: VanEck Australian Floating Rate ETF is trading nearer its 52-week high, Cassava Sciences Inc nearer its low. Which is the better fit depends on your goals.

FLNAFLOT
Market Cap
$53.14M
Sector
HealthSector/Thematic
52-Week High
$4.64$51.09
52-Week Low
$1.09$50.72
Enterprise Value
-$33.43M

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Cassava Sciences Inc

FLNA trades at $1.06, down 2.75% today, with a bearish technical signal from moving averages but neutral oscillators. The stock shows a low P/B of 0.78, yet profitability metrics are negative, including a -79.59% ROE and -$90.97M net income for 2025. Recent Q1 2026 earnings beat expectations, and analyst consensus is 66.7% buy. News highlights Q1 financial results and a scientific presentation on TSC-related epilepsy therapies.

Outlook remains speculative due to persistent losses and negative cash flows, offset by strong analyst support and recent earnings beats. Key risks include funding needs for drug development and competitive pressures, while potential upside hinges on clinical progress in TSC-related epilepsy treatments.

VanEck Australian Floating Rate ETF

FLOT (iShares Floating Rate Bond ETF) trades at $50.97, showing minimal daily movement with a neutral technical signal. The ETF focuses on high-quality floating rate bonds with a 4.0% SEC yield, positioning it as a defensive holding amid rising rate expectations. Recent dividends of $0.17-$0.18 reflect steady income generation, while technical indicators show mixed signals with bullish moving averages but bearish ADX readings.

The outlook remains stable with potential upside if the Federal Reserve implements rate hikes later in 2026, which would boost FLOT's yield. However, the ETF faces headwinds from inflation pressures and geopolitical tensions affecting Treasury yields. Current neutral sentiment suggests FLOT serves as a cash parking vehicle rather than a growth investment, with limited price appreciation potential but reliable income generation.

Returns comparison

Trailing returns across standard periods

About Cassava Sciences Inc

Cassava Sciences Inc is a clinical-stage biotechnology company engaged in developing a scientific approach for the treatment and detection of Alzheimer's disease. Its therapeutic product candidate is called simufilam, and it is a novel treatment for Alzheimer's disease

Read more on FLNA

About VanEck Australian Floating Rate ETF

FLOT provides exposure to a diversified portfolio of Australian dollar-denominated floating rate notes. It tracks the Bloomberg AusBond Credit FRN 0+ Yr Index, focusing on high-quality, investment-grade bonds from top Australian banks and financial institutions.

Read more on FLOT